ABC Laboratories logo

ABC Laboratories

North America, Maryland, United States, Columbia

Description

ABC Laboratories provides IND-enabling and lifecycle management of agrochemicals and pharmaceuticals.

Investor Profile

ABC Laboratories has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Series A rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.

Stage Focus

  • Series Unknown (50%)
  • Series A (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does ABC Laboratories frequently co-invest with?

St. Louis Arch Angels
North America, Missouri, United States, St Louis
Co-Investments: 1
MT
North America, Missouri, United States, Jefferson City
Co-Investments: 2
Cultivation Capital
North America, Missouri, United States, St Louis
Co-Investments: 2
BioGenerator
North America, Missouri, United States, St Louis
Co-Investments: 2
iSelect Fund
North America, Missouri, United States, St Louis
Co-Investments: 1
Helix Fund
North America, Illinois, United States, Chicago
Co-Investments: 2

What are some of recent deals done by ABC Laboratories?

Euclises Pharmaceuticals

St Louis, Missouri, United States

Euclises Pharmaceuticals develops novel COX-2 inhibitors for the effective treatment of cancers in the lungs, colon, and pancreas.

BiotechnologyHealth CarePharmaceutical
Series UnknownSep 23, 2015
Amount Raised: $2,000,000
Euclises Pharmaceuticals

St Louis, Missouri, United States

Euclises Pharmaceuticals develops novel COX-2 inhibitors for the effective treatment of cancers in the lungs, colon, and pancreas.

BiotechnologyHealth CarePharmaceutical
Series ASep 9, 2014
Amount Raised: $1,300,000